Detalhe da pesquisa
1.
Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors.
J Neurooncol
; 167(2): 349-359, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38427131
2.
Clinical impact of molecular profiling in rare brain tumors.
Curr Opin Neurol
; 36(6): 579-586, 2023 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37973025
3.
Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECT.
J Neurooncol
; 165(2): 279-290, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37980692
4.
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial.
J Neurooncol
; 162(1): 137-145, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36884201
5.
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.
J Neurooncol
; 155(3): 363-372, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34761331
6.
Proposed Additions to the NCCN Guidelines for Adult Medulloblastoma.
J Natl Compr Canc Netw
; 18(11): 1579-1584, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33152706
7.
The prevalence of altered body image in patients with primary brain tumors: an understudied population.
J Neurooncol
; 147(2): 397-404, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32096067
8.
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
Cancer
; 125(3): 424-433, 2019 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30359477
9.
Progress in rare central nervous system tumors.
Curr Opin Neurol
; 32(6): 895-906, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31577601
10.
Neurocognitive dysfunction in adult cerebellar medulloblastoma.
Psychooncology
; 28(1): 131-138, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30315720
11.
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity.
J Peripher Nerv Syst
; 24(1): 111-119, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30672664
12.
Updates on Management of Adult Medulloblastoma.
Curr Treat Options Oncol
; 20(8): 64, 2019 06 24.
Artigo
Inglês
| MEDLINE | ID: mdl-31236711
13.
Rethinking medulloblastoma from a targeted therapeutics perspective.
J Neurooncol
; 139(3): 713-720, 2018 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-29869738
14.
NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
J Neurooncol
; 137(1): 39-47, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-29404979
15.
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma.
J Neurooncol
; 131(1): 193-199, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27770279
16.
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma.
J Neurooncol
; 129(3): 487-494, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27406589
17.
Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma.
Pituitary
; 19(4): 415-21, 2016 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-27106209
18.
Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report.
BMC Cancer
; 15: 400, 2015 May 13.
Artigo
Inglês
| MEDLINE | ID: mdl-25962795
19.
Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma.
Cancer
; 125(8): 1385-1386, 2019 04 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30707757
20.
Immunotherapy for Solitary Fibrous Tumor (Hemangiopericytoma): A Unique Treatment Approach for a Rare Central Nervous System Tumor.
Neurologist
; 2024 May 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38797934